Perspectives on the new ESC/EAS dyslipidaemia guidelines and LDL-c targets
This series aims to shed light on what is now established on LDL-c and the risks it confers, and how we can best manage elevated LDL-c levels and why.
Episodes 1-4 of 4
- Perspectives on the new ESC/EAS dyslipidaemia guidelines and LDL-c targetsTranslating ESC/EAS Dyslipidemia Guidelines to clinical practice
Prof Kausik Ray
- Perspectives on the new ESC/EAS dyslipidaemia guidelines and LDL-c targetsLDL-c, atherosclerotic plaques and CV risk - what to do about it
Prof. Thomas Lüscher, MD
- Perspectives on the new ESC/EAS dyslipidaemia guidelines and LDL-c targetsTranslating pathophysiological, genetic and trial data to practical LDL-c treatment recommendations
Professor Ulrich Laufs, MD, PhD
- Perspectives on the new ESC/EAS dyslipidaemia guidelines and LDL-c targetsRationale of new recommendations in ESC/EAS Guidelines for Dyslipidemia
Prof. Ulf Landmesser
